Table 4 Results of GSVA for GSE135917.

BIOCARTA RAB PATHWAY

1.15E − 07

WP GLYCOLYSIS IN SENESCENCE

3.90E − 06

WP INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS

3.77E − 06

KEGG MEDICUS PATHOGEN ESCHERICHIA MAP TO CDC42 SIGNALING PATHWAY

2.09E − 06

REACTOME FORMATION OF APOPTOSOME

6.71E − 06

KEGG MEDICUS VARIANT MUTATION CAUSED ABERRANT SNCA TO 26 S PROTEASOME MEDIATED PROTEIN DEGRADATION

7.09E − 06

KEGG MEDICUS PATHOGEN ESCHERICHIA ESPT TO RAC SIGNALING PATHWAY

2.43E − 06

KEGG MEDICUS VARIANT SCRAPIE CONFORMATION PRPSC TO 26 S PROTEASOME MEDIATED PROTEIN DEGRADATION

1.08E − 05

KEGG MEDICUS VARIANT MUTATION CAUSED ABERRANT ABETA TO 26 S PROTEASOME MEDIATED PROTEIN DEGRADATION

1.00E − 05

REACTOME CYTOCHROME C MEDIATED APOPTOTIC RESPONSE

7.21E − 06

WP AEROBIC GLYCOLYSIS

3.79E − 05

KEGG MEDICUS VARIANT MUTATION CAUSED ABERRANT ABETA TO VGCC CA2 APOPTOTIC PATHWAY N01006

5.70E − 05

KEGG MEDICUS REFERENCE COPII VESICLE FORMATION

2.87E − 05

KEGG MEDICUS PATHOGEN HCMV GB TO PDGFR RAS ERK SIGNALING PATHWAY

1.51E − 05

BIOCARTA PROTEASOME PATHWAY

4.17E − 05

WP GLUTATHIONE METABOLISM

2.37E − 05

KEGG MEDICUS PATHOGEN SHIGELLA IPAC TO ACTIN SIGNALING PATHWAY

1.72E − 05

KEGG MEDICUS REFERENCE BETA OXIDATION

0.000148

REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC

1.77E − 05

KEGG MEDICUS REFERENCE EGF EGFR RAS RALGDS SIGNALING PATHWAY

2.61E − 06